— Know what they know.
Not Investment Advice
Also trades as: 0QF.F (FSX) · $vol 0M

MRNA NASDAQ

Moderna, Inc.
1W: -5.5% 1M: -15.0% 3M: -5.2% YTD: +12.7% 1Y: +76.3% 3Y: -69.6% 5Y: -66.5%
$46.88
-0.38 (-0.80%)
 
Weekly Expected Move ±9.0%
$40 $45 $49 $53 $58
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 27 · $18.6B mcap · 370M float · 2.09% daily turnover · Short 58% of daily vol

Cash Flow Trends

Operating Cash Flow
-$1.9B +37.6% ▲
Capital Expenditures
$192M +81.7% ▲
5Y CAGR: +23.3%
Free Cash Flow
-$2.1B +49.1% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$668M +166.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$12.2B$8.4B-$4.7B-$3.6B-$2.8B
Depreciation & Amort.$232M$348M$621M$189M$215M
Stock-Based Comp.$142M$226M$305M$429M$483M
Change in Working Capital$1.3B-$3.5B-$139M-$78M$254M
Other Non-Cash Items$54M$59M-$19M$17M-$3M
Operating Cash Flow$13.6B$5.0B-$3.1B-$3.0B-$1.9B
— Investing Activities —
Capital Expenditures-$284M-$400M-$707M-$1.1B-$192M
Acquisitions (Net)$0$0-$85M$0$0
Investment Purchases-$12.7B-$11.4B-$3.8B-$6.5B-$5.8B
Investment Sales$4.4B$6.7B$8.8B$9.5B$7.9B
Other Investing-$30M-$40M$0$0-$10M
Investing Cash Flow-$8.5B-$5.2B$4.2B$1.9B$1.9B
— Financing Activities —
Net Debt Issuance-$140M-$184M-$270M-$10M$539M
Stock Repurchased-$857M-$3.3B-$1.2B$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$19M
Financing Cash Flow-$873M-$3.4B-$1.4B$56M$593M
Net Change in Cash$4.2B-$3.6B-$289M-$999M$668M
Cash End of Period$6.9B$3.2B$2.9B$1.9B$2.6B
Free Cash Flow$13.3B$4.6B-$3.8B-$4.1B-$2.1B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms